ATLASATLAS fair value
₩45,406
Below fair value · 64% discount
Range: ₩35,151–₩62,014Fair valuePrice
United Pharm (033270.KO)
United Pharm stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Korea Exchange (KOSPI) · South Korea
₩16,270▼ -3.15%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on United Pharm in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On United Pharm
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates United Pharm's fair value at about ₩45,406 per share (reasonable range: ₩35,151 to ₩62,014). At ₩16,270, the stock trades 64% below it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives United Pharm a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩15,770 and ₩16,923; in 9 out of 10, between ₩14,814 and ₩18,016. Estimated annual volatility is 18%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩270B
- Market cap (USD)
- $204M
- P/E ratio
- 13.8
- Dividend yield
- 3.46%
- 52-week high
- ₩21,800
- 52-week low
- ₩16,100
- Revenue (12 months)
- ₩161B
- Gross margin
- 52.5%
- Operating margin
- 9.9%
- Net margin
- 12.4%
- Beta
- 0.32
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. United Pharm sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 033270.KO has traded between ₩16,100 and ₩21,800. Today it is 25.4% below that high and 1% above its low.
On the business: net margin is 12.4%; it trades at 13.8 times earnings.
Its beta is 0.32: it tends to move less than the market.
About the company
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea.
Want to see everything about United Pharm?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is United Pharm (033270.KO) fair value?
About ₩45,406 per share according to ATLAS (reasonable range: ₩35,151 to ₩62,014). With the stock at ₩16,270, it is 64% below it.
What is the chance 033270.KO goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, 033270.KO ends the month between ₩15,770 and ₩16,923.
How big is United Pharm and what is its P/E ratio?
United Pharm's market capitalization is ₩270B. Its price-to-earnings (P/E) ratio is 13.8: you pay ₩13.8 for each ₩1.00 of yearly earnings.
Does United Pharm pay a dividend?
Yes. 033270.KO's current dividend yield is 3.46% at today's price (₩16,270).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer